Description
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
| Cas No. | 2446480-97-1 |
|---|---|
| Purity | ≥98% |
| Formula | C27H25F3N8O |
| Formula Wt. | 534.55 |
| IUPAC Name | 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine |
| Synonym | USP1-IN-1; KSQ4279 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Cadzow L, Brenneman J, Sullivan P, et al. Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers. Eur J Cancer. 2020 Oct 1;138(Supplement 2,S52).
Cadzow L, Tobin E, Sullivan P, et al. Abstract ND01: KSQ-4279: A first-in-class USP1 inhibitor for the treatment of cancers with homologous recombination deficiencies. Cancer Res. 2022;82(12_Supplement):ND01.
Inhibitor of VEGFR1/2/3.
Peptide, oxytocin analog; potential OXTR agonis...
Potential ATP-sensitive K+ channel blocker, pot...
Non-steroidal MRA
Mycotoxin that has structural similarity to est...
Podophyllotoxin derivative; topoisomerase II in...
Fluorogenic substrate used to measure serine pr...
AhR agonist, dihydroorotate dehydrogenase inhib...
c-MET and Ron inhibitor.
May induce apoptosis in lymphoma cell lines.
Stable salt form of hyperforin, a compound foun...
Macrolide; protein translation inhibitor, mamma...
5-HT2A and TRPV1 antagonist, potential α1-adre...
Peptide; NMDA partial agonist.
Precursor in the synthesis of hydroquinone, ant...
Recombinant protein containing Treponema pallid...
Sulforaphane-cysteine conjugate.
Expectorant.
H+/K+ ATPase inhibitor.